Logo

American Heart Association

  8
  0


Final ID: MDP1341

Assessing Prevalence of Cardiac Amyloidosis at the Time of Spinal Laminectomy for Spinal Stenosis

Abstract Body (Do not enter title and authors here): Introduction:
Cardiac amyloidosis (CA) involves deposition of amyloid fibrils within cardiac myocardium, resulting in heart failure. Recent studies have shown an association between amyloid deposition in the ligamentum flavum (LF) and development of CA. Our study aims to investigate the prevalence of CA in patients identified with amyloid deposition in their LF at the time of spinal laminectomy for spinal stenosis, employing a comprehensive approach integrating multi-modality imaging and laboratory testing.
Methods:
This is a retrospective study of patients age >50 years old who underwent spinal laminectomy for non-congenital spinal stenosis or spondyloarthropathy. LF tissue samples obtained during surgery were examined histologically for amyloid deposition. Patients with positive findings underwent testing, including serum markers, echocardiography, and 99mtechnetium pyrophosphate (99mTcPYP) scintigraphy. Additionally, cardiac magnetic resonance imaging (cMRI) was obtained when clinically appropriate to assess for CA.
Results:
Among the 197 enrolled patients, 39 (19.3%) exhibited amyloid deposition in LF tissue. Patient demographics and clinical characteristics did not significantly differ between the positive and negative groups (Table 1). Of the 39 amyloid positive specimens, subtyping using mass spectrometry identified 1 (3%) light-chain, 28 (72%) transthyretin (TTR), and 10 (25%) were unable to be subtyped. Of the 28 TTR positive patients, 8 were of the wild type genotype. Furthermore, 18 of the 28 TTR patients underwent 99mTcPYP scintigraphy, of which none had cardiac uptake consistent with TTR amyloidosis; the other 10 declined work up. Of the 10 untyped patients, 6 had 99mTcPYP scintigraphy with none of the patients having cardiac uptake. Adjunctive cMRI in select positive patients showed findings inconsistent with amyloid deposition. Serum NT-proBNP, Troponin T, and serum pre-albumin levels were similar between groups.
Conclusion:
Amyloid deposition in LF tissue did not correlate with cardiac manifestations of amyloidosis at the time of surgery. Longitudinal investigation is ongoing to better understand the relationship between amyloid deposition in LF tissue and the development of CA over time.
  • Sul, Lidiya  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Cotta, Claudiu  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Nakashima, Megan  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Steinmetz, Michael  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Kilpatrick, Scott  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Reith, John  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Hanna, Mazen  ( CLEVELAND CLINIC , Cleveland , Ohio , United States )
  • Ives, Lauren  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Schlenk, Richard  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Kalfas, Iain  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Mroz, Thomas  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Orr, Doug  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Benzel, Edward  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Krishnaney, Ajit  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Pelle, Dominic  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Author Disclosures:
    Lidiya Sul: DO NOT have relevant financial relationships | Claudiu Cotta: DO NOT have relevant financial relationships | Megan Nakashima: DO NOT have relevant financial relationships | Michael Steinmetz: No Answer | Scott Kilpatrick: No Answer | John Reith: No Answer | Mazen Hanna: DO have relevant financial relationships ; Advisor:Pfizer:Active (exists now) ; Advisor:Ionis:Active (exists now) ; Advisor:Alexion:Active (exists now) ; Advisor:BridgeBio:Active (exists now) ; Advisor:Alnylam:Active (exists now) | Lauren Ives: DO NOT have relevant financial relationships | Richard Schlenk: No Answer | Iain Kalfas: DO NOT have relevant financial relationships | Thomas Mroz: No Answer | Doug Orr: No Answer | Edward Benzel: No Answer | Ajit Krishnaney: DO have relevant financial relationships ; Consultant:Stryker:Past (completed) | Dominic Pelle: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Improving Detection of Transthyretin Cardiac Amyloidosis

Monday, 11/18/2024 , 11:10AM - 12:35PM

Moderated Digital Poster Session

More abstracts on this topic:
A Beta Tubulin Mutation Suppresses Arrhythmias and Improves Connexin 43 Localization in Heart of Duchenne Muscular Dystrophy Mice

Zhou Delong, Liu Tong, Yehia Ghassan, Romanienko Peter, Rodney George, Wehrens Xander, Lampe Paul, Gourdie Robert, Xie Lai-hua, Fraidenraich Diego, Nouet Julie, Mesa Elam, Yegneshwaran Vasisht, Geukgeuzian Geovanni, Adibemma Ifeanyichukwu, Nandakumar Swetha, Ramirez Edwin, Li Hong

Automated quantification of amyloid burden in cardiac amyloidosis

Greco Francesco, Aimo Alberto, Musetti Veronica, Celi Alessandra, Polito Syria, Castiglione Vincenzo, Vergaro Giuseppe, Emdin Michele, Pucci Angela

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available